Technology
Health
Biotechnology

T2 Biosystems

$2.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-9.97%) Today
+$0.01 (0.38%) After Hours

Why Robinhood?

You can buy or sell T2 Biosystems and other stocks, options, ETFs, and crypto commission-free!

About

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. Read More It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

Employees
153
Headquarters
Lexington, Massachusetts
Founded
2006
Market Cap
116.17M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
683.62K
High Today
$2.87
Low Today
$2.61
Open Price
$2.86
Volume
314.69K
52 Week High
$9.98
52 Week Low
$2.41

Collections

Technology
Health
Biotechnology
2014 IPO
US
North America

News

Yahoo FinanceMay 13

T2 Biosystems Reports Granting of Inducement Awards

LEXINGTON, Mass., May 13, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on May 8, 2019 it issued inducement awards to three new employees. These awards were made under T2 Biosystems’ Inducement Award Plan (the "Inducement Plan"), which was adopted by the company’s Board of Directors on March 1, 2018 and amended and restated on February 21, 2019 an...

146
Seeking AlphaMay 3

T2 Biosystems, Inc. (TTOO) CEO John McDonough on Q1 2019 Results - Earnings Call Transcript

T2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2019 Earnings Conference Call May 2, 2019 4:30 PM ET Company Participants Zack Kubow - W2O Group John McDonough - CEO, President & Director John Sprague - CFO & SVP Thomas Lowery - Chief Scientific Officer Conference Call Participants Jordan Abrams - Cantor Fitzgerald & Co. Mark Massaro - Canaccord Genuity Limited Stephen Brozak - WBB Securities Casey Woodring - Janney Yi Chen - H.C. Wainwright & Co. Soumit Roy - JonesTrading Institutional Services Operator ...

207
Yahoo FinanceMay 2

T2 Biosystems (TTOO) Reports Q1 Loss, Tops Revenue Estimates

T2 Biosystems (TTOO) delivered earnings and revenue surprises of -13.33% and 31.83%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

123

Earnings

-$0.51
-$0.42
-$0.34
-$0.25
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.